Ligand Pharmaceuticals
LGND
#3634
Rank
S$4.65 B
Marketcap
S$236.50
Share price
-0.49%
Change (1 day)
46.31%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Net assets

Net assets on the balance sheet as of September 2025 : S$1.22 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has S$1.22 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ligand Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$1.12 B21.94%
2023-12-31$S$0.92 B15.57%
2022-12-31$S$0.80 B-27.85%
2021-12-31$S$1.11 B18.27%
2020-12-31$S$0.93 B-9.25%
2019-12-31$S$1.03 B34.98%
2018-12-31$S$0.76 B36.85%
2017-12-31$S$0.55 B4.32%
2016-12-31$S$0.53 B37.03%
2015-12-31$S$0.39 B1114.52%
2014-12-31$S$32.25 M-48.69%
2013-12-31$S$62.85 M94.08%
2012-12-31$S$32.38 M205.55%
2011-12-31$S$10.59 M-269.71%
2010-12-31$-S$6.25 Million-218.83%
2009-12-31$S$5.25 M-135.46%
2008-12-31$-S$14.83 Million-135.38%
2007-12-31$S$41.89 M-0.11%
2006-12-31$S$41.94 M-122.81%
2005-12-31$-S$0.19 Billion49.63%
2004-12-31$-S$0.13 Billion92.58%
2003-12-31$-S$63.81 Million-149.68%
2002-12-31$S$0.12 B-219.87%
2001-12-31$-S$0.11 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
S$12.42 B 912.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S$34.61 M-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$27.34 B 2,128.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$67.03 B 5,362.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$120.22 B 9,697.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$30.80 B 2,410.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$24.02 B 1,857.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$9.31 B 659.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$102.37 B 8,243.45%๐Ÿ‡บ๐Ÿ‡ธ USA